Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

37results about How to "High relaxation efficiency" patented technology

Paramagnetic metal complex functionalized fluorogold nano-cluster magnetic resonance and fluorescence imaging contrast agent

The invention provides a paramagnetic metal complex functionalized fluorogold nano-cluster magnetic resonance and fluorescence imaging contrast agent. The invention relates to the field of magnetic resonance imaging and fluorescence imaging contrast agents. With the contrast agent provided by the invention, problems of existing contrast agents of low relaxation efficiency, high toxicity, low tissue organ selectivity and fast in-vivo metabolism can be solved. According to the invention, ethylenediaminetetraacetic acid (EDTA) or diethylene triaminepentaacetic acid (DTPA) are connected to folic-acid-modified bovine serum albumin fluorogold nano-clusters through amide bonds; and EDTA or DTPA is respectively coordinated with paramagnetic metal ions, such that the complex is obtained. With the contrast agent provided by the invention, the relaxation efficiency can reach 23.7mM<-1>*s<-1>. The contrast agent has an advantage of low toxicity. According to the invention, high spatial resolution of magnetic resonance imaging and high sensitivity of fluorescence imaging are combined. Therefore, the contrast agent provided by the invention can be used in magnetic resonance imaging and fluorescence imaging.
Owner:CHANGCHUN UNIV OF TECH

Magnetic resonance imaging contrast using arabinogalactan as carrier

The invention relates to a magnetic resonance image contrast agent which uses arabinogalactan as carrier, wherein its production comprises that: using ethylenediamine tetra acetic acid, diethylene triamine pentacetic acid N-butanimide active ester, ethylenediamine tetra acetic acid, or the anhydrides of diethylene triamine pentacetic, via one short connecting arm to react with amination arabinogalactan; forming amido bond to connect ethylenediamine tetra acetic acid or diethylene triamine pentacetic acid to the arabinogalactan, to match magnetic metal ion as manganese, iron or lanthanide rare-earth element, to obtain complex. The invention has significant liver selectivity and low cute toxin. And the inventive contrast agent can be used in magnetic resonance diagnosis, X-ray CT or Y-flash imaging diagnosis.
Owner:CHANGZHOU INST OF ENERGY STORAGE MATERIALS &DEVICES

Paramagnetic metal complex and synthetic method and application thereof

The invention provides a paramagnetic metal complex and a synthetic method and application thereof. The paramagnetic metal complex is an arabinogalactan-modified 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacethyl paramagnetic metal complex. A magnetic resonance imaging contrast agent prepared from the paramagnetic metal complex has high stability, water solubility and relaxation rate and is targeted to liver and kidney, so that targeted imaging is realized, and the imaging contrast and definition are improved. The paramagnetic metal complex has a good effect on raising the early diagnosis levels of diseases of liver and kidney organs, is about 2 times the relaxation rate of dotarem, has very long targeted radiography imaging time, can be easily prepared into a solution with required concentration for intravenous injection, is suitable for sterilizing and disinfecting with a hot pressing method, can be selectively identified by an asialoglycoprotein receptor on a liver parenchyma surface, and has high selectivity on livers of human beings or other mammals.
Owner:CHANGZHOU INST OF ENERGY STORAGE MATERIALS &DEVICES

Preparation method and application of fluorescence-MRI (Magnetic Resonance Imaging) dual-mode image probe

The invention provides a preparation method and application of a fluorescence-MRI (Magnetic Resonance Imaging) dual-mode image probe, and particularly relates to a dual-mode image probe which combines a fluorescent nanoparticle and a paramagnetic contrast agent and a preparation method thereof, belonging to the field of functional materials. The main process of the method comprises the following step of: removing residues and moisture through dialysis and freeze-drying by taking an amino compound as a surface passivation agent and a gadolinium-based complex as a carbon source material and adopting a one-step forming method to obtain a fluorescence-MRI dual-mode gadolinium-doped carbon quantum dot. The method provided by the invention ahs the characteristics of simple process, low cost and easiness for large-scale production. The fluorescence-MRI dual-mode gadolinium-doped carbon quantum dot prepared through the method has the excellent characteristics of higher fluorescent property, higher relaxation efficiency, good biocompatibility and the like, is successfully applied to in-vitro live cell fluorescence imaging and in-vivo magnetic resonance imaging; the fluorescence-MRI dual-mode gadolinium-doped carbon quantum dot synthesized through the method is about to have wide application prospect in the field of biomedicine.
Owner:JIANGSU UNIV

Similar EDTA ligand containing O-phenolic hydroxyl, as well as non-gadolinium magnetic resonance contrast agent and preparation method thereof

The invention discloses a similar EDTA ligand namely 2,2',2'',2'''-((3-(3,4-dihydroxyphenyl) propane-1,2diyl) ethylene diamine tetraacetic containing O-phenolic hydroxyl, a non-gadolinium paramagnetic metal coordination compound namely a magnetic resonance contrast agent based on the ligand, a non-gadolinium metal agglomeration body namely a magnetic resonance contrast agent, a preparation method of the similar EDTA ligand, a preparation method of the non-gadolinium paramagnetic metal coordination compound namely the magnetic resonance contrast agent, and a preparation method of the non-gadolinium metal agglomeration body namely the magnetic resonance contrast agent. The 2,2',2'',2'''-((3-(3,4-dihydroxyphenyl) propane-1,2diyl) ethylene diamine tetraacetic is prepared for the first time, and the ligand combines the advantages of two structures of the O-phenolic hydroxyl and the EDTA, so that the non-gadolinium magnetic resonance contrast agent based on the ligand has high relaxation efficiency, good water solubility and good structure stability. Compared with a Gd type contrast agent used clinically, the non-gadolinium magnetic resonance contrast agent based on the ligand has the advantages that an order metal agglomeration body namely the contrast agent is self-assembled through coordination, the MRI imaging effects are better, more details can be displayed, and accurate analysis basis is provided for diagnosing multiple diseases.
Owner:川北医学院

A hyperbranched polymer, and a preparing method and applications thereof

The invention relates to the technical field of preparing a contrast agent by utilizing a hyperbranched polymer. A preparing method of the hyperbranched polymer includes reacting a lysine salt and caustic alkali in a mole ratio of 100:80-90 at 140-160 DEG C for 40-50 h in a protective atmosphere; mixing a hyperbranched polylysine skeleton and diethylenetriaminepentaacetic acid according to a mass ratio of at least 1:5 in water; reacting the mixture at room temperature for 6-8 h; mixing the first hyperbranched polylysine molecule and a gadolinium compound in water; reacting the mixture at 37-42 DEG C for 6-12 h, with the mass ratio of the first hyperbranched polylysine molecule to the gadolinium compound being 1:1-1:2; and mixing and reacting the second hyperbranched polylysine molecule and folic acid in a carbonate the pH value of which is 8-10 for 5-12 h. The hyperbranched polylysine contrast agent has good biocompatibility, low toxicity and a high relaxation rate and can be metabolized in vivo.
Owner:SUZHOU INST OF NANO TECH & NANO BIONICS CHINESE ACEDEMY OF SCI

Magnetic resonance contrast agent using human endogenous protein as chelating agent and preparation thereof

The invention relates to a magnetic resonance contrast agent using a human endogenous protein as a chelating agent and preparation thereof. The contrast agent comprises the chelating agent and paramagnetic metal ions coordinated with the chelating agent, the chelating agent is the human endogenous protein, and the human endogenous protein includes aspartic acid and glutamic acid; during the preparation, firstly the human endogenous protein is added to water, the human endogenous protein is dissolved by stirring, and then trisodium citrate dihydrate is added and stirred evenly to obtain a mixedsolution; paramagnetic metal salt is added and stirred to coordinate the paramagnetic metal ions with the chelating agent so as to obtain a reaction solution, finally the pH of the reaction solutionis adjusted to 5.0-7.4, and then the reaction solution is separated and dried. Compared with the prior art, the contrast agent is formed by the direct chelation of the human endogenous protein and theparamagnetic metal ions, and traditional micro-molecule chelating agents are not needed; the contrast agent has simple synthesis process, mild reaction conditions and good environmental compatibility, reduces energy consumption, and is easy in mass production.
Owner:TONGJI UNIV

Paramagnetic metal coordination compound magnetic resonance imaging contrast medium with narrow-leaved oleaster polyose modification

A contrast medium for the magnetic resonance (or X-ray CT) imaging of liver with high selectivity and low poison is prepared from the acid byanhydride of EDTA and DTPA and russianolive gum through reaction and then matching with the 2- or 3- valence ions of paramagnetic metal (Mn or Fe) or La- system RE element to obtain a russianolive gum modified paramagnetic metal match.
Owner:CHANGZHOU INST OF ENERGY STORAGE MATERIALS &DEVICES

Magnetic resonance image probe based on hyaluronic acid-peptide dendrimer-gadolinium conjugates and preparation method thereof

ActiveCN106310296AIncreased longitudinal relaxation efficiencyShorten spin timeIn-vivo testing preparationsDendrimerMRI contrast agent
The invention provides a magnetic resonance image probe based on hyaluronic acid-peptide dendrimer-gadolinium conjugates. The magnetic resonance image probe structurally comprises a plurality of fan-shaped peptide dendrimer and gadolinium conjugates connected onto a hyaluronic acid carbohydrate chain. Hyaluronic acid (HA) is selectively taken as a macromolecular skeleton chain segment, and an MRI contrast agent (Dendronized-HA-Gd) based on the hyaluronic acid-peptide dendrimer-gadolinium conjugates is constructed in combination with the advantages of HA and peptide dendrimer. The structural skeleton has a biodegradable capacity, and a degradable segment is constructed without introducing other sensitive bonds.
Owner:SICHUAN UNIV

Magnetic resonace imaging contrast medium with glycyrrhizic acid as carrier

An MRI contrast medium using glycyrrhizic acid as its carrier is prepared through reaction between the mono-N-hydroxy succinimide (and monocyclic acid anhydride) of EDTA (or biethyltriamino pentacetate) and aminated glycyrrhizic acid, and coordinating with paramagnetic metal ions to obtain a match. It has high elaxation efficiency and selectivity to liver, and lower acute toxin. It can also be used for X-ray CT and gamma-ray flash imaging technique.
Owner:CHANGZHOU INST OF ENERGY STORAGE MATERIALS &DEVICES

Low-field high-relaxation rate magnetic resonance imaging (MRI) contrast agent and preparation method and application thereof

The invention discloses a high-efficiency magnetic resonance imaging (MRI) macromolecular contrast agent applied to low-field MRI and a preparation method and application thereof. The MRI macromolecular contrast agent can be prepared according to the following steps of: a) dissolving a fullerene carboxylic acid derivative in a 2-(N-morpholino) ethanesulfonic acid (MES) buffer solution, adding 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS), and reacting at room temperature to obtain a fullerene carboxylic acid active ester solution; and b) adding gadolinium diethylenetriamine pentaacetic acid human serum albumin (Gd-DTPA-HAS) into the fullerene carboxylic acid active ester solution, stirring, reacting, and then obtaining the MRI contrast agent. The relaxation rate of the Gd-DTPA-HAS-fullerene macromolecular contrast agent is obviously improved under the condition of low field of 0.5T, and obvious tissue contrast ratio can be obtained under the condition of reducing the dosage of the contrast agent; and most importantly, the MRI contrast agent can be used as an MRI molecular probe which can be used for exploring body distribution andmetabolism behavior of nanometer materials such as functionalized fullerene derivatives.
Owner:赤峰福纳康生物技术有限公司 +1

Tumor diagnosis and treatment integrated nano material based on manganese base, preparation method and application

The invention discloses a tumor diagnosis and treatment integrated nano material based on manganese base, a preparation method and application. According to the preparation method, albumin, hypericinand manganese chloride are added into an aqueous medium, and the product is self-assembled to form the tumor diagnosis and treatment integrated nano material. An efficient manganese-base nanoscale macromolecular contrast agent is prepared through self-assembly and has the advantages of being high in relaxation efficiency, long in in-vivo circulation time, rapid in kidney removal, high in targetingproperty and biocompatibility, small in toxic and side effect and the like. The nano material prepared by the invention has relatively high photodynamic conversion efficiency at 595nm, can be used asa photosensitizer to be applied to photodynamic therapy. In addition, the position and size of a tumor and the enrichment condition of the phototherapeutic agent in tumor tissue are monitored by means of a magnetic resonance technology, the nano material is used for evaluating the treatment effect, and magnetic resonance imaging-mediated photodynamic therapy diagnosis and treatment integration isachieved.
Owner:ZHEJIANG UNIV

2-nuclear magnetic resonance imaging contrast agent taking 2, 3-biquinoxaline as connecting body and preparation method thereof

The invention discloses a 2-nuclear magnetic resonance imaging contrast agent taking 2, 3-biquinoxaline as a connecting body and a preparation method of the 2-nuclear magnetic resonance imaging contrast agent, relating to the technical field of magnetic resonance imaging contrast agents. The 2-nuclear magnetic resonance imaging contrast agent taking the 2, 3-biquinoxaline as the connecting body solves the problems that the relaxation efficiency is low and the thermodynamic stability is poor as the contrast agent adopts a flexible chain to connect a group in the prior art. According to the contrast agent, two DO3A groups are in covalent connection on the rigid-connection group 2, 3-biquinoxaline, and then the rigid-connection group 2, 3-biquinoxaline is chelated with paramagnetism metal ion Gd3<+> to obtain the 2-nuclear magnetic resonance imaging contrast agent. The invention also provides the preparation method of the 2-nuclear magnetic resonance imaging contrast agent taking the 2, 3-biquinoxaline as the connecting body. The relaxation efficiency of the contrast agent (Gd-Do3A)-BMQX can achieve 6.2mM<-1>s<-1>, and the 2-nuclear magnetic resonance imaging contrast agent has good stability and is low in toxicity.
Owner:CHANGZHOU INST OF ENERGY STORAGE MATERIALS &DEVICES

Water-soluble magnetic resonance imaging contrast agent containing nitroimidazole group and preparation method of contrast agent

The invention relates to a water-soluble magnetic resonance imaging contrast agent containing a nitroimidazole group and a preparation method of the contrast agent, belonging to the technical fields of medicine and chemistry. The contrast agent is prepared by the following steps: carrying out an esterification reaction between an active derivative of polyaminopolycarboxylate and a compound containing the nitroimidazole group under the effect of microwave to obtain a novel organic ligand containing the nitroimidazole group; and chelating the ligand with paramagnetic metal ions to obtain a corresponding paramagnetic metal chelate contrast agent. The contrast agent disclosed by the invention is high in relaxation efficiency and good in water solubility, and especially has a kidney targeting property; and the contrast agent is applicable to the magnetic resonance imaging technology of various tissues or organs of human bodies or other mammals.
Owner:GUANGDONG UNIV OF TECH

A kind of preparation method and application of fluorescent-mri dual-modality imaging probe

The invention provides a preparation method and application of a fluorescence-MRI (Magnetic Resonance Imaging) dual-mode image probe, and particularly relates to a dual-mode image probe which combines a fluorescent nanoparticle and a paramagnetic contrast agent and a preparation method thereof, belonging to the field of functional materials. The main process of the method comprises the following step of: removing residues and moisture through dialysis and freeze-drying by taking an amino compound as a surface passivation agent and a gadolinium-based complex as a carbon source material and adopting a one-step forming method to obtain a fluorescence-MRI dual-mode gadolinium-doped carbon quantum dot. The method provided by the invention ahs the characteristics of simple process, low cost and easiness for large-scale production. The fluorescence-MRI dual-mode gadolinium-doped carbon quantum dot prepared through the method has the excellent characteristics of higher fluorescent property, higher relaxation efficiency, good biocompatibility and the like, is successfully applied to in-vitro live cell fluorescence imaging and in-vivo magnetic resonance imaging; the fluorescence-MRI dual-mode gadolinium-doped carbon quantum dot synthesized through the method is about to have wide application prospect in the field of biomedicine.
Owner:JIANGSU UNIV

Low-field high-relaxation rate magnetic resonance imaging (MRI) contrast agent and preparation method

The invention discloses a high-efficiency magnetic resonance imaging (MRI) macromolecular contrast agent applied to low-field MRI and a preparation method and application thereof. The MRI macromolecular contrast agent can be prepared according to the following steps of: a) dissolving a fullerene carboxylic acid derivative in a 2-(N-morpholino) ethanesulfonic acid (MES) buffer solution, adding 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS), and reacting at room temperature to obtain a fullerene carboxylic acid active ester solution; and b) adding gadolinium diethylenetriamine pentaacetic acid human serum albumin (Gd-DTPA-HAS) into the fullerene carboxylic acid active ester solution, stirring, reacting, and then obtaining the MRI contrast agent. The relaxation rate of the Gd-DTPA-HAS-fullerene macromolecular contrast agent is obviously improved under the condition of low field of 0.5T, and obvious tissue contrast ratio can be obtained under the condition of reducing the dosage of the contrast agent; and most importantly, the MRI contrast agent can be used as an MRI molecular probe which can be used for exploring body distribution and metabolism behavior of nanometer materials such as functionalized fullerene derivatives.
Owner:赤峰福纳康生物技术有限公司 +1

Paramagnetic metal complex modified by aspartic acid-leucine copolymer and its preparation method and application

InactiveCN104069515BTargetedImprove the level of early diagnosisEmulsion deliveryIn-vivo testing preparationsDiseaseSolubility
The invention relates to a paramagnetic metal complex modified by an aspartic acid-leucine copolymer as well as a preparation method and an application of the paramagnetic metal complex, and is used for solving the technical problems of low biodegradability, low liver targeting property, immunity defects and the like of the existing liver-type macromolecular contrast agent. The paramagnetic metal complex is formed by taking the aspartic acid-leucine copolymer as a carrier, wherein annular 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid ligands are connected on side chains of the carrier. A magnetic resonance imaging contrast agent prepared from the paramagnetic metal complex provided by the invention has the characteristics of a corresponding polyamine multi-carboxy complex, so that the magnetic resonance imaging contrast agent is good in stability, water solubility and relaxation rate, and simultaneously has the targeting property to the liver so as to realize the targeted imaging to improve the imaging contrast ratio and the imaging definition. Thus, the magnetic resonance imaging contrast agent has a good effect for improving the early-stage diagnosis level of diseases of the liver organs.
Owner:CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI

Paramagnetism metal complex magnetic resonance imaging contrast agent containing asparaginic acid-glucan and preparation method of contrast agent

The invention provides a paramagnetism metal complex magnetic resonance imaging contrast agent containing asparaginic acid-glucan and a preparation method of the contrast agent, to solve the problem that in the prior art the contrast agent is low in relaxation rate. According to the contrast agent, the glucan is used as a carrier; asparaginic acid is connected with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and is further subjected to coordination with the paramagnetism metal ions in a mole ratio of 1:1 so as to obtain the complex. According to the preparation method of the paramagnetism metal complex magnetic resonance imaging contrast agent containing the asparaginic acid-glucan, the contrast agent with relatively higher relaxation efficiency is obtained by controlling the dosage ratio of reaction raw materials, the pH value of solution, the reaction temperature and the reaction time. The contrast agent can be used for magnetic resonance imaging; after the contrast agent imaging is accomplished, the asparaginic acid carried in the contrast agent has protection function on hearts, and therefore the contrast agent is an imaging contrast agent with double functions.
Owner:CHANGZHOU INST OF ENERGY STORAGE MATERIALS &DEVICES

A nanomaterial for magnetic resonance imaging and/or photothermal therapy and preparation method thereof

The invention discloses a nanometer material for magnetic resonance imaging and / or photo-thermal treatment and a preparation method thereof and belongs to the field of diagnosis and treatment integration of photo-thermal treatment mediated by the magnetic resonance imaging. The preparation method for the nanometer material comprises the following steps: partially oxidizing catechol into semiquinone or quinone with high activity under the effect of cupric ions under the heating condition of dopamine modified gadolinium compound and dopamine modified polyethylene glycol in an aqueous medium, and then agglomerating the product, thereby acquiring the nanometer material. According to the invention, a micromolecular gadolinium contrast agent is transformed into a macromolecular gadolinium contrast agent through oxidative coupling reaction; the macromolecular gadolinium contrast agent has the advantages of high relaxation efficiency, long in vivo cycling time, low targeting and toxic or side effect, and the like; the nanometer material prepared according to the invention has higher photo-thermal conversion efficiency in a near-infrared area and can be used as a photo-thermal treatment agent in the photo-thermal treatment; and a magnetic resonance technique can be utilized to confirm the position and size of the tumor and the enrichment condition of the photo-thermal treatment agent in the tumor tissue and can be used for evaluating the treatment effect.
Owner:ZHEJIANG UNIV

Magnetic resonance contrast agent as well as preparation method and application thereof

The invention provides a magnetic resonance contrast agent as well as a preparation method and application thereof, and relates to the field of magnetic resonance contrast agents. The magnetic resonance contrast agent disclosed by the invention is prepared from a compound with structural characteristics of a formula I shown in the description. The magnetic resonance contrast agent disclosed by the invention can also be a compound with structural characteristics shown as a formula II or pharmaceutically acceptable salt thereof, M1 is a +2 ion of paramagnetic metal Mn, Fe, Eu or Dy, or a +3 ion of Mn, Fe, Eu or Dy; M2 is Na < + >, K < + > or meglumine cation; when M1 is a +2 valence ion, a is equal to 2; and when M1 is a + 3 valence ion, a is equal to 3. The magnetic resonance contrast agent has the characteristics of good water solubility, high relaxation efficiency, low toxic and side effects and the like.
Owner:GUANGZHOU PINGLAN MEDICAL TECH CO LTD

Preparation and application of superparamagnetic carbon nanotube contrast agent

The invention discloses the preparation and the application of a superparamagnetic carbon nanotube contrast agent, belonging to the technique magnetic resonance imaging. A traditional magnetic resonance imaging technique has small signal strength difference among benign tumor tissue, malignant tumor tissue and normal tissue and cannot achieve the purpose of accurate diagnosis. A multi-wall carbonnanotube and ferrocene are uniformly mixed to prepare a superparamagnetic multi-wall carbon nanotube by a high-temperature thermal decomposition method; then, after anionic polymers and cationic polymers are assembled and packed by layers, a water-soluble multi-wall superparamagnetic carbon nanotube, the surface of which has amino groups, is prepared and is connected with targeting agent folic acid by chemical bonds to further functional operation; and the water-soluble multi-wall superparamagnetic carbon nanotube is used as a targeting nuclear magnetic resonance contrast agent transfected tocervical cancer Hela cells cultured in vitro for enhancing MRI image effect. The invention has the advantages of simple preparation method of the contrast agent, small toxicity, high relaxation efficiency, good biological compatibility, suitability of various biological systems, good imaging effect and convenient diagnosis.
Owner:SHANGHAI NORMAL UNIVERSITY

Paramagnetism metal complex magnetic resonance imaging contrast agent containing asparaginic acid-glucan and preparation method of contrast agent

The invention provides a paramagnetism metal complex magnetic resonance imaging contrast agent containing asparaginic acid-glucan and a preparation method of the contrast agent, to solve the problem that in the prior art the contrast agent is low in relaxation rate. According to the contrast agent, the glucan is used as a carrier; asparaginic acid is connected with 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), and is further subjected to coordination with the paramagnetism metal ions in a mole ratio of 1:1 so as to obtain the complex. According to the preparation method of the paramagnetism metal complex magnetic resonance imaging contrast agent containing the asparaginic acid-glucan, the contrast agent with relatively higher relaxation efficiency is obtained by controlling the dosage ratio of reaction raw materials, the pH value of solution, the reaction temperature and the reaction time. The contrast agent can be used for magnetic resonance imaging; after the contrast agent imaging is accomplished, the asparaginic acid carried in the contrast agent has protection function on hearts, and therefore the contrast agent is an imaging contrast agent with double functions.
Owner:CHANGZHOU INST OF ENERGY STORAGE MATERIALS &DEVICES

A class of gadolinium-containing magnetic resonance imaging contrast agent and its preparation and application

The invention relates to a gadolinium-containing magnetic resonance imaging contrast agent and preparation and application thereof. The gadolinium-containing magnetic resonance imaging contrast agent is prepared by connecting phenyl groups to DOTA-NHNH2 groups and then chelating the paramagnetic metal ion of Gd+. The structural formula of the gadolinium-containing magnetic resonance imaging contrast agent is shown as the formula. The gadolinium-containing magnetic resonance imaging contrast agent is a phenyl substituent group-containing non-ionic magnetic resonance imaging contrast agent, improves the lipophilic performance by introducing the hydrophobic groups and meanwhile achieves selectivity of liver imaging.
Owner:阿克索南京生物科技有限公司

Preparation method and application of single-atom gadolinium contrast agent supported on hollow nitrogen-doped carbon spheres

The invention provides a preparation method and application of a single-atom gadolinium contrast agent supported by hollow nitrogen-doped carbon spheres. The method prepares size-controllable nano-silica microspheres as a template, simultaneously coats dopamine and gadolinium ions on the surface of nano-silica microspheres, and obtains nitrogen-doped carbon-supported single-atom gadolinium through high-temperature calcination; then The silicon dioxide is etched away, and the surface is coated with a hydrophilic polymer to obtain a PEGylated hollow nitrogen-doped carbon sphere loaded monoatomic gadolinium contrast agent. Through the above method, the unique Gd-N-C structure of the present invention can make the monoatomic gadolinium anchored stably by the nitrogen atom without falling off, which improves the biological safety, and the polyethylene glycol coated on the surface further improves its water solubility and biocompatibility; the single-atom contrast agent can make full use of each gadolinium atom, which improves the utilization rate of metal atoms; it has excellent contrast imaging ability and effect, and is a new type of contrast agent with wide application and good prospects.
Owner:BEIJING INSTITUTE OF TECHNOLOGYGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products